Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer

被引：0
|
作者：
Mohammed A Aleskandarany
Andrew R Green
Ahmed A Benhasouna
Fabricio F Barros
Keith Neal
Jorge S Reis-Filho
Ian O Ellis
Emad A Rakha
机构：
[1] University of Nottingham and Nottingham University Hospitals NHS Trust,Department of Histopathology, School of Molecular Medical Sciences, Queens Medical Centre
[2] Menoufia University,Pathology Department, Faculty of Medicine
[3] Shebin El-Kom,Occupational Health, School of Molecular Medical Sciences, Queens Medical Centre
[4] University of Nottingham and Nottingham University Hospitals NHS Trust,Breakthrough Breast Cancer Research Centre
[5] Institute of Cancer Research,undefined
来源：
Breast Cancer Research | / 14卷
关键词：
Breast Cancer; Mitotic Count; Breast Cancer Specific Survival; Luminal Tumor; Invasive Breast Cancer Case;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Implications of high tumor infiltrating lymphocytes (TIL) in HER2-positive and triple-negative breast cancer (TNBC).
    Kotoula, Vassiliki
    Chatzopoulos, Kyriakos
    Lakis, Sotiris
    Alexopoulou, Zoi
    Timotheadou, Eleni
    Zagouri, Flora
    Pentheroudakis, George E.
    Gogas, Helen
    Galani, Eleni P.
    Tsolaki, Eleftheria
    Chrisafi, Sofia
    Koutras, Angelos
    Aravantinos, Gerasimos
    Papakostas, Pavlos
    Kosmidis, Paris A.
    Pectasides, Dimitrios G.
    Fountzilas, George
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Sequencing of chemotherapy and surgery among older triple-negative and HER2-positive breast cancer patients with comorbidities
    Dharanikota, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1482 - S1482
  • [33] Prognostic value of the progesterone receptor by proliferation rate in patients with luminal HER2 negative breast cancer
    Van Asten, Kathleen
    Van Calster, Ben
    Lintermans, Anneleen
    Brouckaert, Olivier
    Floris, Giuseppe
    Wildiers, Hans
    Neven, Patrick
    CANCER RESEARCH, 2015, 75
  • [34] Is nodal staging necessary for older patients with HER2-positive or triple-negative breast cancers?
    McDonough, Leslie
    Petersen, Lindsay
    Lehrberg, Anna
    Bensenhaver, Jessica
    Qutob, Omar
    Susick, Laura
    Ekkel, Elisabeth
    Thaker, Hemi
    Schwartz, Theresa
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 305 - 305
  • [35] Clinical Significance of HER2-Positive and Triple-Negative Status in Small (≤ 1 cm) Node-Negative Breast Cancer
    Gorshein, Elan
    Klein, Paula
    Boolbol, Susan K.
    Shao, Theresa
    CLINICAL BREAST CANCER, 2014, 14 (05) : 309 - 314
  • [36] Her4-JMa-Receptor as positive prognostic Marker in triple-negative Breast Cancer
    Machleidt, A.
    Diermeier-Daucher, S.
    Moegele, M.
    Seitz, S.
    Klinikhammer-Schalke, M.
    Buchholz, S.
    Ortmann, O.
    Brockhoff, G.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (07) : P57 - P57
  • [37] Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes
    Heaphy, Christopher M.
    Subhawong, Andrea Proctor
    Gross, Amy L.
    Konishi, Yuko
    Kouprina, Nina
    Argani, Pedram
    Visvanathan, Kala
    Meeker, Alan K.
    MODERN PATHOLOGY, 2011, 24 (02) : 194 - 200
  • [38] Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression
    Atallah, Nehal M.
    Haque, Maria
    Quinn, Cecily
    Toss, Michael S.
    Makhlouf, Shorouk
    Ibrahim, Asmaa
    Green, Andrew R.
    Alsaleem, Mansour
    Rutland, Catrin S.
    Allegrucci, Cinzia
    Mongan, Nigel P.
    Rakha, Emad
    EUROPEAN JOURNAL OF CANCER, 2023, 195
  • [39] Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer
    Guo, Liying
    Zhu, Qianwen
    Aisimutuola, Mulati
    Yilamu, Dilimina
    Liu, Sha
    Jakulin, Adina
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (06) : 2147 - 2150
  • [40] Prognostic Value of Multiple Triple-Negative Markers in Breast Cancer
    Lu, S.
    Walter, O.
    Vohra, P.
    Kandil, D.
    Wang, L. J.
    Mercurio, A. M.
    Khan, A.
    MODERN PATHOLOGY, 2010, 23 : 60A - 61A
12345